Novartis Earnings Fall on Slide in Cancer-Drug Sales

Novartis said first-quarter earnings fell as the Swiss company plowed investment into new drug launches to offset a sharp dip in sales of its blockbuster cancer medicine Gleevec.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news